129
Views
0
CrossRef citations to date
0
Altmetric
Review

Primary progressive aphasia: conceptual evolution and challenges

&
Pages 9-18 | Published online: 29 Apr 2016

References

  • Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol. 1982;11(6):592–598.
  • Pick A, Girling DM, Berrios GE. On the relationship between senile cerebral atrophy and aphasia. Hist Psychiatr. 1994;5(20):542–547.
  • Pick A, Girling DM, Berrios GE. On the symptomatology of left-sided temporal lobe atrophy. Hist Psychiatr. 1997;8(29):149–159.
  • Alzheimer A. Über eigenartige Krankheitsfälle des späteren Alters. [On certain peculiar diseases of old age]. Hist Psychiatr. 1991;2(5):74–101. German.
  • Maurer K, Volk S, Gerbaldo H. Auguste D and Alzheimer’s disease. Lancet. 1997;349(9064):1546–1549.
  • Ferraro A, Jervis GA. Pick’s disease: clinicopathologic study with report of two cases. Arch Neurol Psychiatry. 1936;36(4):739–767.
  • Lowenberg K. Pick’s disease: a clinicopathologic contribution. Arch Neurol Psychiatry. 1936;36(4):768–789.
  • Davison C. Circumscribed cortical atrophy in the presenile psychoses – Pick’s disease: a clinicopathologic study. Am J Psychiatry. 1938;94(4):801–818.
  • Nichols IC, Weigner WC. Pick’s disease – a specific type of dementia. Brain. 1938;61(3):237–249.
  • Kahn E, Thompson LJ. Concerning Pick’s disease. Am J Psychiatry. 1934;90(5):937–946.
  • Malamud N, Boyd DA Jr. Pick’s disease with atrophy of the temporal lobes: a clinicopathologic study. Arch Neurol Psychiatry. 1940;43(2):210–222.
  • Hodges JR, Patterson K, Oxbury S, Funnell E. Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. Brain. 1992;115(Pt 6):1783–1806.
  • Mesulam MM. Primary progressive aphasia. Ann Neurol. 2001;49(4):425–432.
  • Hodges JR, Patterson K. Nonfluent progressive aphasia and semantic dementia: a comparative neuropsychological study. J Int Neuropsychol Soc. 1996;2(6):511–524.
  • Grossman M, Mickanin J, Onishi K, et al. Progressive nonfluent aphasia: language, cognitive, and PET measures contrasted with probable Alzheimer’s disease. J Cogn Neurosci. 1996;8(2):135–154.
  • Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. 2nd ed. Philadelphia, PA: Lea and Febiger; 1983.
  • Sonty SP, Mesulam MM, Thompson CK, et al. Primary progressive aphasia: PPA and the language network. Ann Neurol. 2003;53(1):35–49.
  • Warrington EK. The selective impairment of semantic memory. Q J Exp Psychol. 1975;27(4):635–657.
  • Snowden JS, Goulding PJ, Neary D. Semantic dementia: a form of circumscribed cerebral atrophy. Behav Neurol. 1989;2:167–182.
  • Turner RS, Kenyon LC, Trojanowski JQ, Gonatas N, Grossman M. Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia. Ann Neurol. 1996;39(2):166–173.
  • Duffy JR. Apraxia of speech in degenerative neurologic disease. Aphasiology. 2006;20(6):511–527.
  • Ogar J, Slama H, Dronkers N, Amici S, Gorno-Tempini ML. Apraxia of speech: an overview. Neurocase. 2005;11(6):427–432.
  • Tyrrell PJ, Warrington EK, Frackowiak RS, Rossor MN. Heterogeneity in progressive aphasia due to focal cortical atrophy. A clinical and PET study. Brain. 1990;113(Pt 5):1321–1336.
  • Knibb JA, Xuereb JH, Patterson K, Hodges JR. Clinical and pathological characterization of progressive aphasia. Ann Neurol. 2006;59(1):156–165.
  • Gorno-Tempini ML, Dronkers NF, Rankin KP, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 2004;55(3):335–346.
  • Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546–1554.
  • Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006–1014.
  • Chare L, Hodges JR, Leyton CE, et al. New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications. J Neurol Neurosurg Psychiatry. 2014;85(8):865–870.
  • Harris JM, Gall C, Thompson JC, et al. Classification and pathology of primary progressive aphasia. Neurology. 2013;81(21):1832–1839.
  • Leyton CE, Villemagne VL, Savage S, et al. Subtypes of progressive aphasia: application of the international consensus criteria and validation using β-amyloid imaging. Brain. 2011;134(10):3030–3043.
  • Sajjadi SA, Patterson K, Arnold RJ, Watson PC, Nestor PJ. Primary progressive aphasia: a tale of two syndromes and the rest. Neurology. 2012;78(21):1670–1677.
  • Botha H, Duffy JR, Whitwell JL, et al. Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech. Cortex. 2015;69:220–236.
  • Palop JJ, Chin J, Mucke L. A network dysfunction perspective on neurodegenerative diseases. Nature. 2006;443(7113):768–773.
  • Mesulam M. Primary progressive aphasia pathology. Ann Neurol. 2008;63(1):124–125.
  • Mesulam MM. Primary progressive aphasia – a language-based dementia. N Engl J Med. 2003;349(16):1535–1542.
  • Heim S, Pieperhoff P, Grande M, et al. Longitudinal changes in brains of patients with fluent primary progressive aphasia. Brain Lang. 2014;131:11–19.
  • Rogalski E, Cobia D, Harrison TM, Wieneke C, Weintraub S, Mesulam MM. Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia. Neurology. 2011;76(21):1804–1810.
  • Leyton C, Britton A, Hodges J, Halliday G, Kril J. Distinctive pathological mechanism involved in primary progressive aphasias. Neurobiol Aging. 2016;38:82–92.
  • Flanagan EP, Duffy JR, Whitwell JL, Vemuri P, Dickson DW, Josephs KA. Mixed tau and TDP-43 pathology in a patient with unclassifiable primary progressive aphasia. Neurocase. 2016;22(1):55–59.
  • Mesulam MM, Weintraub S, Rogalski EJ, Wieneke C, Geula C, Bigio EH. Asymmetry and heterogeneity of Alzheimer’s and frontotemporal pathology in primary progressive aphasia. Brain. 2014;137(Pt 4):1176–1192.
  • Leyton CE, Hsieh S, Mioshi E, Hodges JR. Cognitive decline in logopenic aphasia: more than losing words. Neurology. 2013;80(10):897–903.
  • Gefen T, Gasho K, Rademaker A, et al. Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia. Brain. 2012;135(5):1554–1565.
  • Leyton CE, Hodges JR, McLean CA, Kril JJ, Piguet O, Ballard KJ. Is the logopenic-variant of primary progressive aphasia a unitary disorder? Cortex. 2015;67(0):122–133.
  • Tu S, Leyton CE, Hodges JR, Piguet O, Hornberger M. Divergent longitudinal propagation of white matter degradation in logopenic and semantic variants of primary progressive aphasia. J Alzheimers Dis. 2015;49(3):853–861.
  • Kumfor F, Landin-Romero R, Devenney E, et al. On the right side? A longitudinal study of left- versus right-lateralized semantic dementia. Brain. 2016;139(Pt 3):986–998.
  • Hodges JR, Mitchell J, Dawson K, et al. Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. Brain. 2010;133(Pt 1):300–306.
  • Josephs KA, Whitwell JL, Duffy JR, et al. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology. 2008;70(1):25–34.
  • Kertesz A, Blair M, McMonagle P, Munoz DG. The diagnosis and course of frontotemporal dementia. Alzheimer Dis Assoc Disord. 2007;21(2):155–163.
  • Machulda MM, Whitwell JL, Duffy JR, et al. Identification of an atypical variant of logopenic progressive aphasia. Brain Lang. 2013;127(2):139–144.
  • Kertesz A, Davidson W, McCabe P, Takagi K, Munoz D. Primary progressive aphasia: diagnosis, varieties, evolution. J Int Neuropsychol Soc. 2003;9(5):710–719.
  • Josephs KA, Duffy JR, Strand EA, et al. Characterizing a neuro-degenerative syndrome: primary progressive apraxia of speech. Brain. 2012;135(5):1522–1536.
  • Deramecourt V, Lebert F, Debachy B, et al. Prediction of pathology in primary progressive language and speech disorders. Neurology. 2010;74(1):42–49.
  • Chow TW, Miller BL, Hayashi VN, Geschwind DH. Inheritance of frontotemporal dementia. Arch Neurol. 1999;56(7):817–822.
  • Rosso SM, Kaat LD, Baks T, et al. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain. 2003;126(9):2016–2022.
  • Goldman JS, Farmer JM, Wood EM, et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology. 2005;65(11):1817–1819.
  • Flanagan EP, Baker MC, Perkerson RB, et al. Dominant frontotemporal dementia mutations in 140 cases of primary progressive aphasia and speech apraxia. Dement Geriatr Cogn Disord. 2015;39(5–6):281–286.
  • Rohrer JD, Guerreiro R, Vandrovcova J, et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology. 2009;73(18):1451–1456.
  • Rogalski EJ, Rademaker A, Harrison TM, et al. ApoE E4 is a susceptibility factor in amnestic but not aphasic dementias. Alzheimer Dis Assoc Disord. 2011;25(2):159–163.
  • Wolk DA, Dickerson BC. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer’s disease. Proc Natl Acad Sci U S A. 2010;107(22):10256–10261.
  • Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol. 1998;43(6):815–825.
  • Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393(6686):702–705.
  • Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA. 1998;95(13):7737–7741.
  • Rosso SM, Kamphorst W, de Graaf B, et al. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain. 2001;124(10):1948–1957.
  • Kertesz A, Kawarai T, Rogaeva E, et al. Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology. 2000;54(4):818–827.
  • Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442(7105):916–919.
  • Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442(7105):920–924.
  • DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245–256.
  • Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257–268.
  • van Swieten J, Spillantini MG. Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol. 2007;17(1):63–73.
  • Bessi V, Bagnoli S, Nacmias B, Tedde A, Sorbi S, Bracco L. Semantic dementia associated with mutation V363I in the tau gene. J Neurol Sci. 2010;296(1–2):112–114.
  • Seelaar H, Kamphorst W, Rosso SM, et al. Distinct genetic forms of frontotemporal dementia. Neurology. 2008;71(16):1220–1226.
  • Ishizuka T, Nakamura M, Ichiba M, Sano A. Familial semantic dementia with P301L mutation in the Tau gene. Dement Geriatr Cogn Disord. 2011;31(5):334–340.
  • Yu CE, Bird TD, Bekris LM, et al. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neuro-degeneration. Arch Neurol. 2010;67(2):161–170.
  • Chen-Plotkin AS, Martinez-Lage M, Sleiman PM, et al. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol. 2011;68(4):488–497.
  • Rohrer JD, Crutch SJ, Warrington EK, Warren JD. Progranulin-associated primary progressive aphasia: a distinct phenotype? Neuropsychologia. 2010;48(1):288–297.
  • Mesulam M, Johnson N, Krefft TA, et al. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol. 2007;64(1):43–47.
  • Snowden JS, Pickering-Brown SM, Mackenzie IR, et al. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain. 2006;129(Pt 11):3091–3102.
  • Davion S, Johnson N, Weintraub S, et al. Clinicopathologic correlation in PGRN mutations. Neurology. 2007;69(11):1113–1121.
  • Le Ber I, Camuzat A, Hannequin D, et al. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain. 2008;131(Pt 3):732–746.
  • Pickering-Brown SM, Rollinson S, Du Plessis D, et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain. 2008;131(Pt 3):721–731.
  • Devenney E, Hornberger M, Irish M, et al. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol. 2014;71(3):331–339.
  • Simon-Sanchez J, Dopper EG, Cohn-Hokke PE, et al. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain. 2012;135(Pt 3):723–735.
  • Hsiung GY, DeJesus-Hernandez M, Feldman HH, et al. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain. 2012;135(Pt 3):709–722.
  • Mahoney CJ, Beck J, Rohrer JD, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain. 2012;135(3):736–750.
  • Boeve BF, Boylan KB, Graff-Radford NR, et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012;135(Pt 3):765–783.
  • Watts GD, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36(4):377–381.
  • Kovach MJ, Waggoner B, Leal SM, et al. Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, paget disease of bone, and frontotemporal dementia. Mol Genet Metab. 2001;74(4):458–475.
  • Kumfor F, Piguet O. Disturbance of emotion processing in fronto-temporal dementia: a synthesis of cognitive and neuroimaging findings. Neuropsychol Rev. 2012;22(3):280–297.
  • Croot K, Ballard K, Leyton CE, Hodges JR. Apraxia of speech and phonological errors in the diagnosis of nonfluent/agrammatic and logopenic variants of primary progressive aphasia. J Speech Lang Hear Res. 2012;55(5):S1562–S1572.
  • Piguet O, Leyton CE, Gleeson LD, Hoon C, Hodges JR. Memory and emotion processing performance contributes to the diagnosis of non-semantic primary progressive aphasia syndromes. J Alzheimers Dis. 2015;44(2):541–547.
  • Flanagan EC, Tu S, Ahmed S, Hodges JR, Hornberger M. Memory and orientation in the logopenic and nonfluent subtypes of primary progressive aphasia. J Alzheimers Dis. 2014;40(1):33–36.
  • Butts AM, Machulda MM, Duffy JR, Strand EA, Whitwell JL, Josephs KA. Neuropsychological profiles differ among the three variants of primary progressive aphasia. J Int Neuropsychol Soc. 2015;21(6):429–435.
  • Graff-Radford J, Duffy JR, Strand EA, Josephs KA. Parkinsonian motor features distinguish the agrammatic from logopenic variant of primary progressive aphasia. Parkinsonism Relat Disord. 2012;18(7):890–892.
  • Josephs KA, Duffy JR, Strand EA, et al. The evolution of primary progressive apraxia of speech. Brain. 2014;137(Pt 10):2783–2795.
  • Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain. 2005;128(Pt 9):1996–2005.
  • Kertesz A. Pick complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy. Neurologist. 2003;9(6):311–317.
  • Josephs KA, Duffy JR. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Curr Opin Neurol. 2008;21(6):688–692.
  • Mion M, Patterson K, Acosta-Cabronero J, et al. What the left and right anterior fusiform gyri tell us about semantic memory. Brain. 2010;133(11):3256–3268.
  • Irish M, Hodges JR, Piguet O. Right anterior temporal lobe dysfunction underlies theory of mind impairments in semantic dementia. Brain. 2014;137(Pt 4):1241–1253.
  • Gomez-Tortosa E, Rigual R, Prieto-Jurczynska C, et al. Behavioral evolution of progressive semantic aphasia in comparison with nonfluent aphasia. Dement Geriatr Cogn Disord. 2015;41(1–2):1–8.
  • Patterson K, Nestor PJ, Rogers TT. Where do you know what you know? The representation of semantic knowledge in the human brain. Nat Rev Neurosci. 2007;8(12):976–987.
  • Nestor PJ, Graham NL, Fryer TD, Williams GB, Patterson K, Hodges JR. Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain. 2003;126(Pt 11):2406–2418.
  • Josephs KA, Duffy JR, Strand EA, et al. Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA. Neurology. 2013;81(4):337–345.
  • Ballard KJ, Savage S, Leyton CE, Vogel AP, Hornberger M, Hodges JR. Logopenic and nonfluent variants of primary progressive aphasia are differentiated by acoustic measures of speech production. PLoS One. 2014;9(2):e89864.
  • Gorno-Tempini ML, Murray RC, Rankin KP, Weiner MW, Miller BL. Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case report. Neurocase. 2004;10(6):426–436.
  • Maas E, Robin DA, Wright DL, Ballard KJ. Motor programming in apraxia of speech. Brain Lang. 2008;106(2):107–118.
  • New AB, Robin DA, Parkinson AL, et al. Altered resting-state network connectivity in stroke patients with and without apraxia of speech. Neuroimage Clin. 2015;8:429–439.
  • Leyton CE, Ballard KJ, Piguet O, Hodges JR. Phonologic errors as a clinical marker of the logopenic variant of PPA. Neurology. 2014;82:1636–1642.
  • Leyton CE, Hodges JR. Towards a clearer definition of logopenic progressive aphasia. Curr Neurol Neurosci Rep. 2013;13(11):396.
  • Savage SA, Ballard KJ, Piguet O, Hodges JR. Bringing words back to mind – improving word production in semantic dementia. Cortex. 2013;49(7):1823–1832.
  • Nickels L, Croot K. Progressive language impairments: intervention and management. Aphasiology. 2009;23(2):123–124.
  • Savage SA, Piguet O, Hodges JR. Cognitive intervention in semantic dementia: maintaining words over time. Alzheimer Dis Assoc Disord. 2015;29(1):55–62.
  • Rogalski E, Weintraub S, Mesulam MM. Are there susceptibility factors for primary progressive aphasia? Brain Lang. 2013;127(2):135–138.
  • Miller ZA, Mandelli ML, Rankin KP, et al. Handedness and language learning disability differentially distribute in progressive aphasia variants. Brain. 2013;136(Pt 11):3461–3473.